SBFM — Sunshine Biopharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Sunshine Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1.66	-2.78	-12.4	-26.7	-4.51
Depreciation
Deferred Taxes
Non-Cash Items	1.18	2.16	10.7	18.3	0
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.031	-0.043	-0.109	3.15	-4.42
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities	-0.496	-0.657	-1.83	-5.25	-8.78
Capital Expenditures	-0.001	-0.001	0	-0.305	-0.788
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.014	0	0	-14.3	0.132
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities	-0.015	-0.001	0	-14.6	-0.656
Financing Cash Flow Items	0.028	0	—	28.3	4.09
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.442	1.61	2.9	39.5	3.43
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.075	0.949	1.06	19.8	-5.53